Kiniksa Pharmaceuticals Ltd Stock Performance
as on May 8, 2026 at 5:08 am IST
Day's Low
Day's High
$55.76$57.62
1.33%
Downside
1.96%
Upside
52 Week's Low
52 Week's High
$24.85$58.2656.03%
Downside
3.10%
Upside
Kiniksa Pharmaceuticals Ltd share price movements today
- Previous Close
- $58.23
- Open
- $57.62
- Volume
- 625.6K
- Day's Low - High
- $55.76 - $57.62
- 52 Week Low - High
- $24.85 - $58.26
Kiniksa Pharmaceuticals Ltd Historical Returns
- 1 Month Return
- + 18.98 %
- 3 Month Return
- + 35.14 %
- 1 Year Return
- + 117.52 %
- 3 Year Return
- + 325.35 %
- 5 Year Return
- + 298.02 %
Kiniksa Pharmaceuticals Ltd Stock Fundamentals & Key Indicators
Check Kiniksa Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.5B
EPS (TTM)
1.2
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.46%
PE Ratio (TTM)
63.99
Industry PE ratio
19.188181818181818
PEG Ratio
0EBITDA
94.8M
Revenue (TTM)
754.0M
Profit Margin
9.69%
Return On Equity TTM
11.73%
Kiniksa Pharmaceuticals Ltd Stock Valuation
Track how Kiniksa Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Kiniksa Pharmaceuticals Ltd in the last 5 years
Lowest (-174.01x)
September 30, 2024
Industry (19.19x)
May 7, 2026
Today (63.99x)
May 7, 2026
Highest (177.55x)
March 31, 2024
Today’s Price to Earnings Ratio: 63.99x
Kiniksa Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kiniksa Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.5B | 298.02% | 63.99 | 9.69% | |
| BUY | $25.3B | NA | 21.41 | 41.94% | |
| HOLD | $18.1B | 13.28% | NA | -24.58% | |
| BUY | $41.0B | NA | 18.46 | 15.11% | |
| BUY | $46.9B | -35.17% | 18.48 | 28.24% |
Stock Returns calculator for Kiniksa Pharmaceuticals Ltd Stock including INR - Dollar returns
The Kiniksa Pharmaceuticals Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kiniksa Pharmaceuticals Ltd investment value today
Current value as on today
₹2,34,811
Returns
₹1,34,811
(+134.81%)
Returns from Kiniksa Pharmaceuticals Ltd Stock
₹1,11,095 (+111.09%)
Dollar Impact
₹23,717 (+23.72%)
Analyst Recommendation on Kiniksa Pharmaceuticals Ltd Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Kiniksa Pharmaceuticals Ltd. Average target price of $63.5
Kiniksa Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Kiniksa Pharmaceuticals Ltd.
What analysts predicted
11.01%UPSIDE
Target Price
$63.5
Current Price
$56.51
Analyzed by
11 Analysts
Target
$63.50
Kiniksa Pharmaceuticals Ltd target price $63.5, a slight upside of 11.01% compared to current price of $56.51. According to 11 analysts rating.
Indian Investors' Interest in Kiniksa Pharmaceuticals Ltd Stock
Search interest for Kiniksa Pharmaceuticals Ltd Stock has increased by 1688% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1688% versus previous 30 day period
Kiniksa Pharmaceuticals Ltd Quarterly Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals Ltd Annual Profit & Loss
All numbers in Millions USD
Kiniksa Pharmaceuticals Ltd Quarterly Cash Flow
All numbers in Millions USD
Kiniksa Pharmaceuticals Ltd Annual Cash Flow
All numbers in Millions USD
Insights on Kiniksa Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 14.19M → 22.59M (in $), with an average increase of 37.2% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, KNSA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 9 quarters, 79.85M → 214.26M (in $), with an average increase of 11.4% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KNSA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 years, KNSA stock has moved up by 325.3%
About Kiniksa Pharmaceuticals Ltd
| Organisation | Kiniksa Pharmaceuticals Ltd |
| Headquarters | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Mr. Sanj K. Patel |
| E-voting on shares | Click here to vote |
Key Management of Kiniksa Pharmaceuticals Ltd
Name | Title |
|---|---|
Ms. Martina Struck Ph.D. | Senior VP & Chief Regulatory Officer |
Mr. Sanj K. Patel | CEO & Chairman of the Board |
Mr. Michael R. Megna CPA | Senior VP & Chief Accounting Officer |
Mr. Douglas Barry | Senior VP, Chief Legal Officer & Secretary |
Mr. Eben Tessari | Executive VP & Chief Strategy Officer |
Ms. Mei Jang | Senior VP & Chief Technical Officer |
Mr. Jonathan Kirshenbaum | Investor Relations Officer |
Mr. Mark A. Ragosa C.F.A. | Executive VP & CFO |
Mr. Ross Michael Moat | Executive VP, COO & Principal Operating Officer |
Dr. John F. Paolini FACC, M.D., Ph.D. | Executive VP & Chief Medical Officer |
FAQs
What is Kiniksa Pharmaceuticals Ltd share price today?
Kiniksa Pharmaceuticals Ltd share price today is $56.51 as on . Kiniksa Pharmaceuticals Ltd share today touched a day high of $57.62 and a low of $55.76.
What is the 52 week high and 52 week low for Kiniksa Pharmaceuticals Ltd share?
Kiniksa Pharmaceuticals Ltd share touched a 52 week high of $58.26 on and a 52 week low of $24.85 on . Kiniksa Pharmaceuticals Ltd stock price today i.e. is trending at $56.51,which is 3.00% down from its 52 week high and 127.40% up from its 52 week low.
What is Kiniksa Pharmaceuticals Ltd's market capitalisation today?
Kiniksa Pharmaceuticals Ltd market capitalisation is $0.00T as on .
How to invest in Kiniksa Pharmaceuticals Ltd Stock (KNSA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kiniksa Pharmaceuticals Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiniksa Pharmaceuticals Ltd Shares that will get you 0.0265 shares as per Kiniksa Pharmaceuticals Ltd share price of $56.51 per share as on May 7, 2026 at 11:38 pm IST.
What is the minimum amount required to buy Kiniksa Pharmaceuticals Ltd Stock (KNSA) from India?
Indian investors can start investing in Kiniksa Pharmaceuticals Ltd (KNSA) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Kiniksa Pharmaceuticals Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kiniksa Pharmaceuticals Ltd share’s latest price of $56.51 as on May 7, 2026 at 11:38 pm IST, you will get 0.1770 shares of Kiniksa Pharmaceuticals Ltd. Learn more about
fractional shares .
What are the returns that Kiniksa Pharmaceuticals Ltd has given to Indian investors in the last 5 years?
Kiniksa Pharmaceuticals Ltd stock has given 298.02% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?